{"id":4367,"date":"2026-09-18T11:45:27","date_gmt":"2026-09-18T03:45:27","guid":{"rendered":"https:\/\/launxp.com\/?p=4367"},"modified":"2026-09-21T10:47:44","modified_gmt":"2026-09-21T02:47:44","slug":"%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer","status":"publish","type":"post","link":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/","title":{"rendered":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"4367\" class=\"elementor elementor-4367\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-60b8af8 e-flex e-con-boxed e-con e-parent\" data-id=\"60b8af8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f34b676 elementor-widget elementor-widget-heading\" data-id=\"f34b676\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u91cd\u5927\u8baf\u606f<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0d76e95 elementor-widget elementor-widget-heading\" data-id=\"0d76e95\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative\nBreast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b\n\u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0875264 elementor-widget-divider--view-line_icon elementor-widget-divider--element-align-right elementor-view-default elementor-widget elementor-widget-divider\" data-id=\"0875264\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon elementor-divider__element\">\n\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-angle-double-down\" viewbox=\"0 0 320 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M143 256.3L7 120.3c-9.4-9.4-9.4-24.6 0-33.9l22.6-22.6c9.4-9.4 24.6-9.4 33.9 0l96.4 96.4 96.4-96.4c9.4-9.4 24.6-9.4 33.9 0L313 86.3c9.4 9.4 9.4 24.6 0 33.9l-136 136c-9.4 9.5-24.6 9.5-34 .1zm34 192l136-136c9.4-9.4 9.4-24.6 0-33.9l-22.6-22.6c-9.4-9.4-24.6-9.4-33.9 0L160 352.1l-96.4-96.4c-9.4-9.4-24.6-9.4-33.9 0L7 278.3c-9.4 9.4-9.4 24.6 0 33.9l136 136c9.4 9.5 24.6 9.5 34 .1z\"><\/path><\/svg><\/div>\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d5807fd e-flex e-con-boxed e-con e-parent\" data-id=\"d5807fd\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-56221c1 e-con-full e-flex e-con e-child\" data-id=\"56221c1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-87775f1 e-con-full e-flex e-con e-child\" data-id=\"87775f1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-338510f elementor-widget elementor-widget-heading\" data-id=\"338510f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u5e8f\u865f<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8618726 elementor-widget elementor-widget-heading\" data-id=\"8618726\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">3<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-8816d0e e-con-full e-flex e-con e-child\" data-id=\"8816d0e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3089618 elementor-widget elementor-widget-heading\" data-id=\"3089618\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u767c\u8a00\u65e5\u671f<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-84901e7 elementor-widget elementor-widget-heading\" data-id=\"84901e7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\"><span>115\/09\/18<\/span><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-175838f e-con-full e-flex e-con e-child\" data-id=\"175838f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d765325 elementor-widget elementor-widget-heading\" data-id=\"d765325\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u767c\u8a00\u6642\u9593\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cdb34a1 elementor-widget elementor-widget-heading\" data-id=\"cdb34a1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">14:44:12<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6c0cc88 e-con-full e-flex e-con e-child\" data-id=\"6c0cc88\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-809471b elementor-widget elementor-widget-heading\" data-id=\"809471b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u767c\u8a00\u4eba\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-242eb0c elementor-widget elementor-widget-heading\" data-id=\"242eb0c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u9673\u4e18\u7d18<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3874c4b e-con-full e-flex e-con e-child\" data-id=\"3874c4b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-227a4f3 elementor-widget elementor-widget-heading\" data-id=\"227a4f3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u767c\u8a00\u4eba\u8077\u7a31<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9e261b0 elementor-widget elementor-widget-heading\" data-id=\"9e261b0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u7e3d\u7d93\u7406\n\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1fc86fa e-con-full e-flex e-con e-child\" data-id=\"1fc86fa\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7ca9eed elementor-widget elementor-widget-heading\" data-id=\"7ca9eed\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u767c\u8a00\u4eba\u96fb\u8a71\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b2731da elementor-widget elementor-widget-heading\" data-id=\"b2731da\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">04-23205691<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-78b59c3 e-con-full e-flex e-con e-child\" data-id=\"78b59c3\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5a77dfe elementor-widget elementor-widget-heading\" data-id=\"5a77dfe\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u7b26\u5408\u689d\u6b3e\t\u7b2c\t44\t\u6b3e<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9758e2c e-con-full e-flex e-con e-child\" data-id=\"9758e2c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a55b667 elementor-widget elementor-widget-heading\" data-id=\"a55b667\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">\u4e8b\u5be6\u767c\u751f\u65e5\t<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f82ae39 elementor-widget elementor-widget-heading\" data-id=\"f82ae39\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">115\/09\/17<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-13f6eb2 e-con-full e-flex e-con e-child\" data-id=\"13f6eb2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4327237 elementor-widget elementor-widget-heading\" data-id=\"4327237\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u4e3b\u65e8<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cf3d7c7 elementor-widget elementor-widget-text-editor\" data-id=\"cf3d7c7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-78c7f33 elementor-widget elementor-widget-heading\" data-id=\"78c7f33\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u8aaa\u660e<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9dd523d elementor-widget elementor-widget-text-editor\" data-id=\"9dd523d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/17<\/p><p>2.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f8<\/p><p>3.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f8<\/p><p>4.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u7528<\/p><p>5.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological complete response, pCR\uff09\uff0c\u7d44\u5247\u672a\u89c0\u5bdf\u5230pCR\u3002 \u4e0a\u8ff0\u7d50\u679c\u61c9\u8996\u70ba\u63a2\u7d22\u6027\u7642\u6548\u8a0a\u865f\uff0c\u5c1a\u7121\u6cd5\u64da\u4ee5\u5efa\u7acbLXP105\u4e4b\u6bd4\u8f03\u6027\u7642\u5176\u99185\u4f4d\u4ea6\u5448 \u73fe\u4e0d\u540c\u7a0b\u5ea6\u4e4b\u75c5\u7406\u9000\u7e2e\uff1bNACT\u55ae\u7368\u6548\u7d50\u8ad6\uff0c\u5f8c\u7e8c\u4ecd\u9700\u900f\u904e\u8f03\u5927\u578b\u3001\u524d\u77bb\u6027\u53ca\u5c0d\u7167 \u6027\u81e8\u5e8a\u7814\u7a76\u9032\u4e00\u6b65\u9a57\u8b49\u3002<\/p><p>6.\u56e0\u61c9\u63aa\u65bd:\u7121\u3002<\/p><p>7.\u5176\u4ed6\u61c9\u6558\u660e\u4e8b\u9805(\u82e5\u4e8b\u4ef6\u767c\u751f\u6216\u6c7a\u8b70\u4e4b\u4e3b\u9ad4\u4fc2\u5c6c\u516c\u958b\u767c\u884c\u4ee5\u4e0a\u516c\u53f8\uff0c \u672c\u5247\u91cd\u5927\u8a0a\u606f\u540c\u6642\u7b26\u5408\u8b49\u5238\u4ea4\u6613\u6cd5\u65bd\u884c\u7d30\u5247\u7b2c7\u689d\u7b2c9\u6b3e\u6240\u5b9a \u5c0d\u80a1\u6771\u6b0a\u76ca\u6216\u8b49\u5238\u50f9\u683c\u6709\u91cd\u5927\u5f71\u97ff\u4e4b\u4e8b\u9805):<\/p><p>(1)LXP105\u70ba\u4e00\u7a2e\u8840\u6e05\u7d20\uff0d\u53bb\u7532\u814e\u4e0a\u817a\u7d20\u518d\u651d\u53d6\u6291\u5236\u5291\uff08Serotonin-Norepinephrine Reuptake Inhibitor, SNRI\uff09\u3002\u4e0d\u540c\u65bc\u50b3\u7d71\u76f4\u63a5\u6bba\u6b7b\u816b\u7624\u7d30\u80de\u4e4b\u7d30\u80de\u6bd2\u6027\u85e5\u7269\uff0c \u672c\u7814\u7a76\u63d0\u51fa\u4e4b\u5de5\u4f5c\u5047\u8aaa\u70baLXP105\u53ef\u80fd\u900f\u904e\u8abf\u7bc0\u55ae\u80fa\u985e\u8a0a\u865f\uff0c\u5f71\u97ff\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u4e4b \u8840\u7ba1\u3001\u514d\u75ab\u8207\u7d30\u80de\u58d3\u529b\u53cd\u61c9\uff0c\u9032\u800c\u6210\u70ba\u6a19\u6e96\u6297\u764c\u6cbb\u7642\u4e4b\u6f5b\u5728\u8f14\u52a9\u7b56\u7565\uff1b\u6b64\u6a5f\u5236\u76ee \u524d\u4ecd\u5c6c\u7814\u7a76\u5047\u8aaa\uff0c\u6709\u5f85\u5f8c\u7e8c\u8f49\u8b6f\u7814\u7a76\u53ca\u524d\u77bb\u6027\u81e8\u5e8a\u8a66\u9a57\u9a57\u8b49\u3002<\/p><p>(2)\u672c\u516c\u53f8\u73fe\u968e\u6bb5\u6838\u5fc3\u7814\u767c\u8cc7\u6e90\u4ecd\u5c07\u96c6\u4e2d\u63a8\u9032\u4e3b\u529b\u7522\u54c1LXP103\u4e4b\u81e8\u5e8a\u958b\u767c\u9032\u7a0b\uff1b \u91dd\u5c0dLXP105\uff0c\u5c07\u4f9d\u672c\u6b21TNBC\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u6210\u679c\uff0c\u6301\u7e8c\u6df1\u5316\u4f5c\u7528\u6a5f\u5236\u3001\u8f49\u8b6f\u91ab \u5b78\u53ca\u751f\u7269\u6a19\u8a18\u7814\u7a76\uff0c\uff0c\u4e26\u8a55\u4f30\u5176\u65bc\u4e0d\u540cTNBC\u6cbb\u7642\u60c5\u5883\u4e4b\u767c\u5c55\u53ef\u80fd\u6027\uff0c\u5305\u62ec\u8207\u73fe \u884c\u514d\u75ab\u6cbb\u7642\u7b56\u7565\u4e4b\u6574\u5408\uff0c\u4ee5\u53ca\u672a\u4f86\u91dd\u5c0d\u514d\u75ab\u6cbb\u7642\u53cd\u61c9\u4e0d\u4f73\u6216\u6cbb\u7642\u5f8c\u75be\u75c5\u9032\u5c55\u60a3 \u8005\u4e4b\u6f5b\u5728\u81e8\u5e8a\u958b\u767c\u65b9\u5411\u3002<\/p><p>(3)\u76f8\u95dc\u81e8\u5e8a\u5b9a\u4f4d\u3001\u8a66\u9a57\u8a2d\u8a08\u8207\u958b\u767c\u6642\u7a0b\uff0c\u5c07\u4f9d\u5f8c\u7e8c\u79d1\u5b78\u8b49\u64da\u3001\u6cd5\u898f\u7b56\u7565\u53ca\u516c\u53f8 \u6574\u9ad4\u7814\u767c\u8cc7\u6e90\u914d\u7f6e\u5be9\u614e\u898f\u5283\uff0c\u4ee5\u671f\u9032\u4e00\u6b65\u78ba\u8a8dLXP105\u4e4b\u81e8\u5e8a\u50f9\u503c\u3002<\/p><p>(4)\u65b0\u85e5\u7814\u767c\u5177\u6709\u9ad8\u5ea6\u4e0d\u78ba\u5b9a\u6027\u53ca\u98a8\u96aa\uff0c\u672c\u6b21\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u7d50\u679c\u53ca\u5b78\u8853\u671f\u520a\u63a5 \u53d7\u520a\u767b\uff0c\u4e26\u4e0d\u4ee3\u8868\u5f8c\u7e8c\u81e8\u5e8a\u8a66\u9a57\u3001\u4e3b\u7ba1\u6a5f\u95dc\u5be9\u67e5\u3001\u85e5\u8b49\u53d6\u5f97\u6216\u5546\u696d\u5316\u4e00\u5b9a\u6210\u529f\uff0c \u6295\u8cc7\u4eba\u61c9\u5be9\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/17 2.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f8 3.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f8 4.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u7528 5.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-4367","post","type-post","status-publish","format-standard","hentry","category-info"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/172.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f83.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f84.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u75285.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Donna\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"zh_CN\" \/>\n\t\t<meta property=\"og:site_name\" content=\"LaunXP Biomedical - Developing new cancer drugs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 | LaunXP Biomedical\" \/>\n\t\t<meta property=\"og:description\" content=\"Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/172.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f83.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f84.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u75285.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/website_thumbnai.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/website_thumbnai.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1527\" \/>\n\t\t<meta property=\"og:image:height\" content=\"888\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-18T03:45:27+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-21T02:47:44+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 | LaunXP Biomedical\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/172.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f83.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f84.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u75285.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/website_thumbnai.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#blogposting\",\"name\":\"\\u66f4\\u6b63\\u516c\\u544a\\u672c\\u516c\\u53f8LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c(Triple-Negative Breast Cancer, TNBC\\uff09\\u65b0\\u8f14\\u52a9\\u6cbb\\u7642\\u7684\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\uff0c\\u7372\\u570b\\u969b \\u816b\\u7624\\u5b78\\u671f\\u520a\\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002 | LaunXP Biomedical\",\"headline\":\"\\u66f4\\u6b63\\u516c\\u544a\\u672c\\u516c\\u53f8LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c(Triple-Negative Breast Cancer, TNBC\\uff09\\u65b0\\u8f14\\u52a9\\u6cbb\\u7642\\u7684\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\uff0c\\u7372\\u570b\\u969b \\u816b\\u7624\\u5b78\\u671f\\u520a\\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002\",\"author\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/author\\\/donna\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/launxp.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/logo-round.png\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/#articleImage\",\"width\":512,\"height\":512},\"datePublished\":\"2026-09-18T11:45:27+08:00\",\"dateModified\":\"2026-09-21T10:47:44+08:00\",\"inLanguage\":\"zh-CN\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#webpage\"},\"articleSection\":\"Information\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/launxp.com\\\/cn\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/category\\\/info\\\/#listItem\",\"name\":\"Information\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/category\\\/info\\\/#listItem\",\"position\":2,\"name\":\"Information\",\"item\":\"https:\\\/\\\/launxp.com\\\/cn\\\/category\\\/info\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#listItem\",\"name\":\"\\u66f4\\u6b63\\u516c\\u544a\\u672c\\u516c\\u53f8LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c(Triple-Negative Breast Cancer, TNBC\\uff09\\u65b0\\u8f14\\u52a9\\u6cbb\\u7642\\u7684\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\uff0c\\u7372\\u570b\\u969b \\u816b\\u7624\\u5b78\\u671f\\u520a\\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#listItem\",\"position\":3,\"name\":\"\\u66f4\\u6b63\\u516c\\u544a\\u672c\\u516c\\u53f8LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c(Triple-Negative Breast Cancer, TNBC\\uff09\\u65b0\\u8f14\\u52a9\\u6cbb\\u7642\\u7684\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\uff0c\\u7372\\u570b\\u969b \\u816b\\u7624\\u5b78\\u671f\\u520a\\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/category\\\/info\\\/#listItem\",\"name\":\"Information\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/#organization\",\"name\":\"LaunXP Biomedical\",\"description\":\"Developing new cancer drugs\",\"url\":\"https:\\\/\\\/launxp.com\\\/cn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/launxp.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/logo-round.png\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#organizationLogo\",\"width\":512,\"height\":512},\"image\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/author\\\/donna\\\/#author\",\"url\":\"https:\\\/\\\/launxp.com\\\/cn\\\/author\\\/donna\\\/\",\"name\":\"Donna\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#authorImage\",\"url\":\"https:\\\/\\\/launxp.com\\\/wp-content\\\/litespeed\\\/avatar\\\/fc57b2e7fd816105a77ba5f231669cb0.jpg?ver=1791784769\",\"width\":96,\"height\":96,\"caption\":\"Donna\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#webpage\",\"url\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/\",\"name\":\"\\u66f4\\u6b63\\u516c\\u544a\\u672c\\u516c\\u53f8LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c(Triple-Negative Breast Cancer, TNBC\\uff09\\u65b0\\u8f14\\u52a9\\u6cbb\\u7642\\u7684\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\uff0c\\u7372\\u570b\\u969b \\u816b\\u7624\\u5b78\\u671f\\u520a\\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002 | LaunXP Biomedical\",\"description\":\"Material Information \\u66f4\\u6b63\\u516c\\u544a\\u672c\\u516c\\u53f8LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c(Triple-Negative Breast Cancer, TNBC\\uff09\\u65b0\\u8f14\\u52a9\\u6cbb\\u7642\\u7684\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\uff0c\\u7372\\u570b\\u969b \\u816b\\u7624\\u5b78\\u671f\\u520a\\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002 \\u5e8f\\u865f 3 \\u767c\\u8a00\\u65e5\\u671f 115\\\/09\\\/18 \\u767c\\u8a00\\u6642\\u9593 14:44:12 \\u767c\\u8a00\\u4eba \\u9673\\u4e18\\u7d18 \\u767c\\u8a00\\u4eba\\u8077\\u7a31 \\u7e3d\\u7d93\\u7406 \\u767c\\u8a00\\u4eba\\u96fb\\u8a71 04-23205691 \\u7b26\\u5408\\u689d\\u6b3e \\u7b2c 44 \\u6b3e \\u4e8b\\u5be6\\u767c\\u751f\\u65e5 115\\\/09\\\/17 \\u4e3b\\u65e8 \\u66f4\\u6b63\\u516c\\u544a\\u672c\\u516c\\u53f8LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c(Triple-Negative Breast Cancer, TNBC\\uff09\\u65b0\\u8f14\\u52a9\\u6cbb\\u7642\\u7684\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\uff0c\\u7372\\u570b\\u969b \\u816b\\u7624\\u5b78\\u671f\\u520a\\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002 \\u8aaa\\u660e 1.\\u4e8b\\u5be6\\u767c\\u751f\\u65e5:115\\\/09\\\/172.\\u516c\\u53f8\\u540d\\u7a31:\\u6717\\u9f4a\\u751f\\u7269\\u91ab\\u5b78\\u80a1\\u4efd\\u6709\\u9650\\u516c\\u53f83.\\u8207\\u516c\\u53f8\\u95dc\\u4fc2(\\u8acb\\u8f38\\u5165\\u672c\\u516c\\u53f8\\u6216\\u5b50\\u516c\\u53f8):\\u672c\\u516c\\u53f84.\\u76f8\\u4e92\\u6301\\u80a1\\u6bd4\\u4f8b:\\u4e0d\\u9069\\u75285.\\u767c\\u751f\\u7de3\\u7531: \\u672c\\u516c\\u53f8\\u5019\\u9078\\u85e5\\u7269LXP105\\u61c9\\u7528\\u65bc\\u7b2c\\u4e8c\\u671f\\u4e09\\u9670\\u6027\\u4e73\\u764c\\uff08Triple-Negative Breast Cancer, TNBC\\uff09\\u8f14\\u52a9\\u6cbb\\u7642\\u4e4b\\u63a2\\u7d22\\u6027\\u81e8\\u5e8a\\u7814\\u7a76\\u8ad6\\u6587\\uff0c\\u7d93\\u540c\\u5115\\u5be9\\u67e5\\u5f8c\\u7372\\u570b\\u969b\\u816b\\u7624\\u5b78\\u671f\\u520a \\u300aFrontiers in Oncology\\u300b\\u63a5\\u53d7\\uff0c\\u4e26\\u6e96\\u5099\\u767c\\u8868\\u3002 \\u672c\\u7814\\u7a76\\u4ee5LXP105\\u5408\\u4f75\\u6a19\\u6e96\\u65b0\\u8f14\\u52a9\\u5316\\u7642\\uff08Neoadjuvant Chemotherapy, NACT\\uff09\\uff0c \\u63a2\\u7d22\\u5176\\u65bcTNBC\\u60a3\\u8005\\u4e4b\\u81e8\\u5e8a\\u53ef\\u884c\\u6027\\u3001\\u5b89\\u5168\\u6027\\u3001\\u5f71\\u50cf\\u5b78\\u816b\\u7624\\u8b8a\\u5316\\uff0c\\u4ee5\\u53ca\\u8207\\u816b\\u7624\\u5fae\\u74b0\\u5883 \\u76f8\\u95dc\\u4e4b\\u514d\\u75ab\\u751f\\u7269\\u6a19\\u8a18\\u8b8a\\u5316\\u3002\\u672c\\u7814\\u7a76\\u70ba\\u55ae\\u4e2d\\u5fc3\\u63a2\\u7d22\\u6027\\u7814\\u7a76\\uff0c\\u7d50\\u679c\\u986f\\u793aLXP105\\u52a0\\u5165\\u6a19 \\u6e96\\u65b0\\u8f14\\u52a9\\u5316\\u7642\\u5177\\u6709\\u826f\\u597d\\u4e4b\\u81e8\\u5e8a\\u53ef\\u884c\\u6027\\uff0c\\u7814\\u7a76\\u671f\\u9593\\u672a\\u767c\\u73fe\\u975e\\u9810\\u671f\\u4e4b\\u5b89\\u5168\\u6027\\u8a0a\\u865f\\uff0c\\u4ea6 \\u7121\\u60a3\\u8005\\u56e0LXP105\\u76f8\\u95dc\\u4e0d\\u826f\\u53cd\\u61c9\\u800c\\u9700\\u8abf\\u6574\\u5291\\u91cf\\u6216\\u4e2d\\u6b62\\u6cbb\\u7642\\u3002 \\u5728\\u5f71\\u50cf\\u5b78\\u816b\\u7624\\u53cd\\u61c9\\u65b9\\u9762\\uff0c\\u63a5\\u53d7LXP105\\u5408\\u4f75NACT\\u6cbb\\u7642\\u4e4b7\\u4f4d\\u60a3\\u8005\\u7686\\u89c0\\u5bdf\\u5230\\u53ef\\u6e2c\\u91cf\\u4e4b\\u539f \\u767c\\u816b\\u7624\\u7e2e\\u5c0f\\uff0c\\u7e2e\\u5c0f\\u5e45\\u5ea6\\u4ecb\\u65bc45.0%\\u81f3100%\\uff0c\\u4e2d\\u4f4d\\u816b\\u7624\\u7e2e\\u5c0f\\u5e45\\u5ea6\\u905477.3%\\uff1bNACT\\u55ae\\u7368 \\u6cbb\\u7642\\u7d44\\u89c0\\u5bdf\\u5230\\u4e4b\\u4e2d\\u4f4d\\u7e2e\\u5c0f\\u5e45\\u5ea6\\u5247\\u70ba43.4%\\u3002\\u6b64\\u5916\\uff0cLXP105\\u5408\\u4f75\\u6cbb\\u7642\\u7d44\\u4e2d\\u67092\\u4f4d\\u60a3\\u8005 \\u9054\\u75c5\\u7406\\u5b8c\\u5168\\u53cd\\u61c9\\uff08pathological\",\"inLanguage\":\"zh-CN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/info\\\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/author\\\/donna\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/author\\\/donna\\\/#author\"},\"datePublished\":\"2026-09-18T11:45:27+08:00\",\"dateModified\":\"2026-09-21T10:47:44+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/#website\",\"url\":\"https:\\\/\\\/launxp.com\\\/cn\\\/\",\"name\":\"LaunXP Biomedical \\u6717\\u9f4a\\u751f\\u7269\\u91ab\\u5b78\\u80a1\\u4efd\\u6709\\u9650\\u516c\\u53f8\",\"alternateName\":\"\\u6717\\u9f4a\\u751f\\u91ab\",\"description\":\"Developing new cancer drugs\",\"inLanguage\":\"zh-CN\",\"publisher\":{\"@id\":\"https:\\\/\\\/launxp.com\\\/cn\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 | LaunXP Biomedical","description":"Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/172.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f83.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f84.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u75285.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological","canonical_url":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#blogposting","name":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 | LaunXP Biomedical","headline":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002","author":{"@id":"https:\/\/launxp.com\/cn\/author\/donna\/#author"},"publisher":{"@id":"https:\/\/launxp.com\/cn\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/logo-round.png","@id":"https:\/\/launxp.com\/cn\/#articleImage","width":512,"height":512},"datePublished":"2026-09-18T11:45:27+08:00","dateModified":"2026-09-21T10:47:44+08:00","inLanguage":"zh-CN","mainEntityOfPage":{"@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#webpage"},"isPartOf":{"@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#webpage"},"articleSection":"Information"},{"@type":"BreadcrumbList","@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/launxp.com\/cn#listItem","position":1,"name":"Home","item":"https:\/\/launxp.com\/cn","nextItem":{"@type":"ListItem","@id":"https:\/\/launxp.com\/cn\/category\/info\/#listItem","name":"Information"}},{"@type":"ListItem","@id":"https:\/\/launxp.com\/cn\/category\/info\/#listItem","position":2,"name":"Information","item":"https:\/\/launxp.com\/cn\/category\/info\/","nextItem":{"@type":"ListItem","@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#listItem","name":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002"},"previousItem":{"@type":"ListItem","@id":"https:\/\/launxp.com\/cn#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#listItem","position":3,"name":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002","previousItem":{"@type":"ListItem","@id":"https:\/\/launxp.com\/cn\/category\/info\/#listItem","name":"Information"}}]},{"@type":"Organization","@id":"https:\/\/launxp.com\/cn\/#organization","name":"LaunXP Biomedical","description":"Developing new cancer drugs","url":"https:\/\/launxp.com\/cn\/","logo":{"@type":"ImageObject","url":"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/logo-round.png","@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#organizationLogo","width":512,"height":512},"image":{"@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/launxp.com\/cn\/author\/donna\/#author","url":"https:\/\/launxp.com\/cn\/author\/donna\/","name":"Donna","image":{"@type":"ImageObject","@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#authorImage","url":"https:\/\/launxp.com\/wp-content\/litespeed\/avatar\/fc57b2e7fd816105a77ba5f231669cb0.jpg?ver=1791784769","width":96,"height":96,"caption":"Donna"}},{"@type":"WebPage","@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#webpage","url":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/","name":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 | LaunXP Biomedical","description":"Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/172.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f83.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f84.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u75285.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological","inLanguage":"zh-CN","isPartOf":{"@id":"https:\/\/launxp.com\/cn\/#website"},"breadcrumb":{"@id":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/#breadcrumblist"},"author":{"@id":"https:\/\/launxp.com\/cn\/author\/donna\/#author"},"creator":{"@id":"https:\/\/launxp.com\/cn\/author\/donna\/#author"},"datePublished":"2026-09-18T11:45:27+08:00","dateModified":"2026-09-21T10:47:44+08:00"},{"@type":"WebSite","@id":"https:\/\/launxp.com\/cn\/#website","url":"https:\/\/launxp.com\/cn\/","name":"LaunXP Biomedical \u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f8","alternateName":"\u6717\u9f4a\u751f\u91ab","description":"Developing new cancer drugs","inLanguage":"zh-CN","publisher":{"@id":"https:\/\/launxp.com\/cn\/#organization"}}]},"og:locale":"zh_CN","og:site_name":"LaunXP Biomedical - Developing new cancer drugs","og:type":"article","og:title":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 | LaunXP Biomedical","og:description":"Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/172.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f83.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f84.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u75285.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological","og:url":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/","og:image":"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/website_thumbnai.png","og:image:secure_url":"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/website_thumbnai.png","og:image:width":1527,"og:image:height":888,"article:published_time":"2026-09-18T03:45:27+00:00","article:modified_time":"2026-09-21T02:47:44+00:00","twitter:card":"summary_large_image","twitter:title":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 | LaunXP Biomedical","twitter:description":"Material Information \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u5e8f\u865f 3 \u767c\u8a00\u65e5\u671f 115\/09\/18 \u767c\u8a00\u6642\u9593 14:44:12 \u767c\u8a00\u4eba \u9673\u4e18\u7d18 \u767c\u8a00\u4eba\u8077\u7a31 \u7e3d\u7d93\u7406 \u767c\u8a00\u4eba\u96fb\u8a71 04-23205691 \u7b26\u5408\u689d\u6b3e \u7b2c 44 \u6b3e \u4e8b\u5be6\u767c\u751f\u65e5 115\/09\/17 \u4e3b\u65e8 \u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002 \u8aaa\u660e 1.\u4e8b\u5be6\u767c\u751f\u65e5:115\/09\/172.\u516c\u53f8\u540d\u7a31:\u6717\u9f4a\u751f\u7269\u91ab\u5b78\u80a1\u4efd\u6709\u9650\u516c\u53f83.\u8207\u516c\u53f8\u95dc\u4fc2(\u8acb\u8f38\u5165\u672c\u516c\u53f8\u6216\u5b50\u516c\u53f8):\u672c\u516c\u53f84.\u76f8\u4e92\u6301\u80a1\u6bd4\u4f8b:\u4e0d\u9069\u75285.\u767c\u751f\u7de3\u7531: \u672c\u516c\u53f8\u5019\u9078\u85e5\u7269LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c\uff08Triple-Negative Breast Cancer, TNBC\uff09\u8f14\u52a9\u6cbb\u7642\u4e4b\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\u8ad6\u6587\uff0c\u7d93\u540c\u5115\u5be9\u67e5\u5f8c\u7372\u570b\u969b\u816b\u7624\u5b78\u671f\u520a \u300aFrontiers in Oncology\u300b\u63a5\u53d7\uff0c\u4e26\u6e96\u5099\u767c\u8868\u3002 \u672c\u7814\u7a76\u4ee5LXP105\u5408\u4f75\u6a19\u6e96\u65b0\u8f14\u52a9\u5316\u7642\uff08Neoadjuvant Chemotherapy, NACT\uff09\uff0c \u63a2\u7d22\u5176\u65bcTNBC\u60a3\u8005\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\u3001\u5b89\u5168\u6027\u3001\u5f71\u50cf\u5b78\u816b\u7624\u8b8a\u5316\uff0c\u4ee5\u53ca\u8207\u816b\u7624\u5fae\u74b0\u5883 \u76f8\u95dc\u4e4b\u514d\u75ab\u751f\u7269\u6a19\u8a18\u8b8a\u5316\u3002\u672c\u7814\u7a76\u70ba\u55ae\u4e2d\u5fc3\u63a2\u7d22\u6027\u7814\u7a76\uff0c\u7d50\u679c\u986f\u793aLXP105\u52a0\u5165\u6a19 \u6e96\u65b0\u8f14\u52a9\u5316\u7642\u5177\u6709\u826f\u597d\u4e4b\u81e8\u5e8a\u53ef\u884c\u6027\uff0c\u7814\u7a76\u671f\u9593\u672a\u767c\u73fe\u975e\u9810\u671f\u4e4b\u5b89\u5168\u6027\u8a0a\u865f\uff0c\u4ea6 \u7121\u60a3\u8005\u56e0LXP105\u76f8\u95dc\u4e0d\u826f\u53cd\u61c9\u800c\u9700\u8abf\u6574\u5291\u91cf\u6216\u4e2d\u6b62\u6cbb\u7642\u3002 \u5728\u5f71\u50cf\u5b78\u816b\u7624\u53cd\u61c9\u65b9\u9762\uff0c\u63a5\u53d7LXP105\u5408\u4f75NACT\u6cbb\u7642\u4e4b7\u4f4d\u60a3\u8005\u7686\u89c0\u5bdf\u5230\u53ef\u6e2c\u91cf\u4e4b\u539f \u767c\u816b\u7624\u7e2e\u5c0f\uff0c\u7e2e\u5c0f\u5e45\u5ea6\u4ecb\u65bc45.0%\u81f3100%\uff0c\u4e2d\u4f4d\u816b\u7624\u7e2e\u5c0f\u5e45\u5ea6\u905477.3%\uff1bNACT\u55ae\u7368 \u6cbb\u7642\u7d44\u89c0\u5bdf\u5230\u4e4b\u4e2d\u4f4d\u7e2e\u5c0f\u5e45\u5ea6\u5247\u70ba43.4%\u3002\u6b64\u5916\uff0cLXP105\u5408\u4f75\u6cbb\u7642\u7d44\u4e2d\u67092\u4f4d\u60a3\u8005 \u9054\u75c5\u7406\u5b8c\u5168\u53cd\u61c9\uff08pathological","twitter:image":"https:\/\/launxp.com\/wp-content\/uploads\/2024\/10\/website_thumbnai.png"},"aioseo_meta_data":{"post_id":"4367","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-09-21 02:45:31","updated":"2026-09-21 02:45:50","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/launxp.com\/cn\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/launxp.com\/cn\/category\/info\/\" title=\"Information\">Information<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/launxp.com\/cn"},{"label":"Information","link":"https:\/\/launxp.com\/cn\/category\/info\/"},{"label":"\u66f4\u6b63\u516c\u544a\u672c\u516c\u53f8LXP105\u61c9\u7528\u65bc\u7b2c\u4e8c\u671f\u4e09\u9670\u6027\u4e73\u764c(Triple-Negative Breast Cancer, TNBC\uff09\u65b0\u8f14\u52a9\u6cbb\u7642\u7684\u63a2\u7d22\u6027\u81e8\u5e8a\u7814\u7a76\uff0c\u7372\u570b\u969b \u816b\u7624\u5b78\u671f\u520a\u300aFrontiers in Oncology\u300b\u63a5\u53d7\u4e26\u6e96\u5099\u767c\u8868\u3002","link":"https:\/\/launxp.com\/cn\/info\/%e6%9b%b4%e6%ad%a3%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8lxp105%e6%87%89%e7%94%a8%e6%96%bc%e7%ac%ac%e4%ba%8c%e6%9c%9f%e4%b8%89%e9%99%b0%e6%80%a7%e4%b9%b3%e7%99%8ctriple-negative-breast-cancer\/"}],"_links":{"self":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts\/4367","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/comments?post=4367"}],"version-history":[{"count":4,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts\/4367\/revisions"}],"predecessor-version":[{"id":4371,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts\/4367\/revisions\/4371"}],"wp:attachment":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/media?parent=4367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/categories?post=4367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/tags?post=4367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}